We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Increased Probability of Sepsis Mortality Associated with SOFA Score

By LabMedica International staff writers
Posted on 17 Aug 2017
Print article
Image: The compact PATHFAST Immunoanalyzer used for the presepsin point-of-care assay (Photo courtesy of LSI Medience Corporation).
Image: The compact PATHFAST Immunoanalyzer used for the presepsin point-of-care assay (Photo courtesy of LSI Medience Corporation).
Sepsis-related organ failure assessment score, also known as sequential organ failure assessment score (SOFA score), is used to track a person's status during the stay in an intensive care unit (ICU) to determine the extent of a person's organ function or rate of failure.

The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems. Both the mean and highest SOFA scores are predictors of outcome. An increase in SOFA score during the first 24 to 48 hours in the ICU predicts a mortality rate of at least 50% up to 95%. Scores less than nine give predictive mortality at 33% while above 11 can be close to or above 95%.

Scientists at the Diagnostics Engineering & Research GmbH (Dossenheim, Germany) working with their medical colleagues compared sepsis biomarkers with a quick SOFA (qSOFA) for differentiation of sepsis, severe sepsis or septic shock and risk of mortality prediction. The group studied 66 patients admitted with signs of sepsis..Severe sepsis and septic shock were defined according to current guidelines. The qSOFA score was calculated from respiratory rate, Glasgow Coma Scale (GCS) score and systolic blood pressure using the recommended thresholds.

Presepsin (PSEP) and procalcitonin (PCT) were determined using the point of care (POC) assay PATHFAST Presepsin, and the BRAHMS luminescence immune assay. The team reported that discrimination between 30 sepsis (mortality=6.6%) and 36 patients with severe sepsis or septic shock (mortality=36.1%) revealed area under the curve (AUC) values of 0.621, 0.627, 0.731, 0.740 and 0.781 for lactate, PCT, qSOFA, PSEP and the combination qSOFA+PSEP, respectively. Using the threshold ≥2 of qSOFA and ≥500 ng/L of PSEP, the combination qSOFA+PSEP detected 14 non-survivors (93%) and 33/36 (92%) patients of the high-risk group whereas qSOFA alone detected only 10 non-survivors (67%) and 21 patients of the high-risk group (58%).

The authors concluded that their results demonstrated that the qSOFA score is not a standalone criterion for risk stratification in sepsis at admission. Simultaneous assessment by combining qSOFA and PSEP improved the validity significantly. The POC assay PATHFAST Presepsin showed superior performance compared to lactate and PCT. The study was presented at the 69th Annual meeting of American Association for Clinical Chemistry held August 1–3, 2017, in San Diego, CA, USA.

Related Links:
Diagnostics Engineering & Research

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.